Country: United Kingdom
Language: English
Source: MHRA (Medicines & Healthcare Products Regulatory Agency)
Indometacin
Accord-UK Ltd
M01AB01
Indometacin
25mg
Oral capsule
Oral
No Controlled Drug Status
Valid as a prescribable product
BNF: 10010100; GTIN: 5012617010186
296x210 Leaflet Reel Fed Bi Fold Profile (BST) Dimensions: Component: Date Sent: Technologist: TECHNICALLY APPROVED Pharmacode: JDE No.: Indometacin, Capsules, 25 & 50mg, 28s - UK 296x210 (Reel Fed) 51015325 Leaflet for Blisters 3972 RH 31-08-22 * Please note that ONLY Artwork Studio is permitted to make changes to the above artwork. No changes are permitted by any 3rd party other than added notes and mark ups for required changes. approved for print/date PROOF ROUND Technical Approval NON PRINTING COLOURS COLOURS DATE SENT: DATE RECEIVED: Item number: ORIGINATOR: ORIGINATION DATE: REVISION DATE: REVISED BY: DIMENSIONS: MIN BODY TEXT SIZE: SUPPLIER: 1. 2. 3. 4. 5. 6. 1. 2. 3. EU-Artwork-Support@accord-healthcare.com INDOMETACINE 25MG & 50MG 28 TABS PIL - UK Black Profile BBBB5609 M.Ellott 07/09/2022 08/09/2022 M.Ellott 296x210 10pt Accord Barnstaple n/a n/a 2 Version 7 12.02.2020 German GTIN 14 (incorporating PZN): Cartons and label leaflets only (labels only when specified) page 4 page 1 51015325 BBBB5609 INDOMETACIN 25MG AND 50MG CAPSULES READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. • Keep this leaflet. You may need to read it again. • If you have any further questions, ask your doctor or pharmacist. • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. • If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET: 1 WHAT INDOMETACIN CAPSULES ARE AND WHAT THEY ARE USED FOR 2 WHAT YOU NEED TO KNOW BEFORE YOU TAKE INDOMETACIN CAPSULES 3 HOW TO TAKE INDOMETACIN CAPSULES 4 POSSIBLE SIDE EFFECTS 5 HOW TO STORE INDOMETACIN CAPSULES 6 CONTENTS OF THE PACK AND OTHER INFORMATION 1 WHAT INDOMETACIN CAPSULES ARE AND WHAT THEY ARE USED FOR Indometacin capsules belong to a group of medicines called non-steroidal anti-inflammatory drug Read the complete document
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Indometacin Capsules BP 25mg 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each capsule contains 25mg Indometacin Ph.Eur. 3 PHARMACEUTICAL FORM Ivory hard gelatin capsules 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Indometacin has non-steroidal analgesic and anti-inflammatory properties. It is indicated for the following conditions: • active stages of rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, degenerative joint disease of the hip, acute musculoskeletal disorders, gout and lumbago • inflammation, pain and oedema following orthopaedic procedures • treatment of pain and associated symptoms of primary dysmenorrhoea Since indometacin is not a simple analgesic, its use should be limited to the above conditions. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION _ _ Posology The dosage should be carefully adjusted according to the needs of the individual patient, starting with a low dose. To reduce the possibility of gastro-intestinal disturbances, indometacin capsules should always be taken with food, milk or immediately after meals, or with an antacid and in chronic conditions start the therapy with a low dosage, increasing as required. Adults: The recommended oral dosage range is 50-200mg daily. Acute rheumatoid arthritis: Initially 25mg two or three times a day. Chronic rheumatic disorders: 25mg two or three times daily. (If response is inadequate, gradually increase by 25mg. Adequate response is usually achieved with not more than 150mg daily, rarely more than 200mg daily). Sudden flare up of chronic condition: Increase if necessary, by 25mg daily until a satisfactory response is obtained, or a dosage of 150-200mg daily is reached. (If this causes any adverse effects, it should be reduced to a tolerable level for two or three days, then carefully increased, as tolerated). Acute musculoskeletal disorders: Initially 50mg two or three times daily, according to severity for 10-14 days. Normally 150mg daily, rarely 200mg daily. Lumb Read the complete document